Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection

Lancet

Volumn 361, Issue 9361, 2003, Pages 923-929

  Iizuka, Norio ^a   Oka, Masaaki ^a   Yamada Okabe, Hisafumi ^c   Nishida, Minekatsu ^a   Maeda, Yoshitaka ^a   Mori, Naohide ^a   Takao, Takashi ^a   Tamesa, Takao ^a   Tangoku, Akira ^a   Tabuchi, Hisahiro ^c   Hamada, Kenji ^c   Nakayama, Hironobu ^c   Ishitsuka, Hideo ^c   Miyamoto, Takanobu ^b   Hirabayashi, Akira ^b   Uchimura, Shunji ^b   Hamamoto, Yoshihiko ^b  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b YAMAGUCHI UNIVERSITY   (Japan)

^c NIPPON ROCHE RESEARCH CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CANCER RECURRENCE; CANCER SURGERY; CANCER TISSUE; CLINICAL ARTICLE; COMPARATIVE STUDY; DNA MICROARRAY; DNA VECTOR; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0037443891     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)12775-4     Document Type: Article

References (31)

1. Okuda K. Hepatocellular carcinoma. J Hepatol. 32:2000;225-237.
2. Iizuka N., Oka M., Noma T., Nakazawa A., Hirose K., Suzuki T. NM23-H1 and NM23-H2 messenger RNA abundance in human hepatocellular carcinoma. Cancer Res. 55:1995;652-657.
3. Poon R.T., Fan S.T., Ng I.O., Lo C.M., Liu C.L., Wong J. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer. 89:2000;500-507.
4. Izumi R., Shimizu K., Ii T., et al. Prognostic factors of hepatocellular carcinoma in patient undergoing hepatic resection. Gastroenterology. 106:1994;720-727.
5. Hsu H.C., Tseng H.J., Lai P.L., Lee P.H., Peng S.Y. Expression of p53 gene in 184 unifocal hepatocellular carcinomas: association with tumor growth and invasiveness. Cancer Res. 53:1993;4691-4694.
6. Mathew J., Hines J.E., Obafunwa J.O., Burr A.W., Toole K., Burt A.D. CD44 is expressed in hepatocellular carcinomas showing vascular invasion. J Pathol. 179:1996;74-79.
7. Schena M., Shalon D., Davis R.W., Brown P.O. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science. 270:1995;467-470.
8. DeRisi J., Penland L., Brown P.O., et al. Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat Genet. 14:1996;457-460.
9. Alizadeh A.A., Eisen M.B., Davis R.E., et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 403:2000;503-511.
10. Scherf U., Ross D.T., Waltham M., et al. A gene expression database for the molecular pharmacology of cancer. Nat Genet. 24:2000;236-244.
11. Brazma A., Vilo J. Gene expression data analysis. FEBS Lett. 480:2000;17-24.
12. Eisen M.B., Spellman P.T., Brown P.O., Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA. 95:1998;14863-14868.
13. Kell D.B., King R.D. On the optimization of classes for the assignment of unidentified reading frames in functional genomics programmes: the need for machine learning. Trends Biotechnol. 18:2000;93-98.
14. Golub T.R., Slonim D.K., Tamayo P., et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science. 286:1999;531-537.
15. Brown M.P., Grundy W.N., Lin D., et al. Knowledge-based analysis of microarray gene expression data by using support vector machines. Proc Natl Acad Sci USA. 97:2000;262-267.
16. Khan J., Wei J.S., Ringner M., et al. Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Nat Med. 7:2001;673-679.
17. Luo J., Duggan D.J., Chen Y., et al. Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling. Cancer Res. 61:2001;4683-4688.
18. Iizuka N., Oka M., Yamada-Okabe H., et al. Comparison of gene expression profiles between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data based on a supervised learning method. Cancer Res. 62:2002;3939-3944.
19. Jain A.K., Duin R.P.W., Mao J. Statistical pattern recognition: a review. IEEE Trans Pattern Analysis Machine Intelligence. 22:2000;4-37.
20. Sobin L.H., Wittekind C. TNM classification of Malignant Tumours. 6th edn: 2002;81-83 UICC, Wiley-Liss, New York.
21. Lipshutz R.L., Fodor S.P.A., Gingeras T.R., Lockhart D.J. High density oligonucleotide arrays. Nat Genet. 21:1999;20-24.
22. Duda R.O., Hart P.E., Stork D.G. Pattern classification. 2nd edn: 2001;1-152 John Wiley and Sons, New York.
23. Furey T.S., Cristianini N., Duffy N., Bednarski D.W., Schummer M., Haussler D. Support vector machine classification and validation of cancer tissue samples using microarray expression data. Bioinformatics. 16:2000;906-914.
24. Okabe H., Satoh S., Kato T., et al. Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression. Cancer Res. 61:2001;2129-2137.
25. Shirota Y., Kaneko S., Honda M., Kawai H.F., Kobayashi K. Identification of differentially expressed genes in hepatocellular carcinoma with cDNA microarrays. Hepatology. 33:2001;832-840.
26. Xu L., Hui L., Wang S., et al. Expression profiling suggested a regulatory role of liver-enriched transcription factors in human hepatocellular carcinoma. Cancer Res. 61:2001;3176-3181.
27. He K.L., Ting A.T. A20 inhibits tumor necrosis factor (TNF) alpha-induced apoptosis by disrupting recruitment of TRADD and RIP to the TNF receptor 1 complex in Jurkat T cells. Mol Cell Biol. 22:2002;6034-6045.
28. Cabrera T., Ruiz-Cabello F., Garrido F. Biological implications of HLA-DR expression in tumours. Scand J Immunol. 41:1995;398-406.
29. Tissot C., Mechti N. Molecular cloning of a new interferon-induced factor that represses human immunodeficiency virus type 1 long terminal repeat expression. J Biol Chem. 270:1995;14891-14898.
30. Takayama T., Sekine T., Makuuchi M., et al. Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial. Lancet. 356:2000;802-807.
31. Evron E.C., Umbricht D., Korz V., et al. Loss of cyclin D2 expression in the majority of breast cancers is associated with promoter hypermethylation. Cancer Res. 61:2001;2782-2787.